Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia
- 1 August 1989
- journal article
- research article
- Published by Elsevier in Biological Psychiatry
- Vol. 26 (4) , 381-388
- https://doi.org/10.1016/0006-3223(89)90054-1
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- HaloperidolArchives of General Psychiatry, 1984
- Monitoring of haloperidol serum levels and it's clinical significanceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1984
- Clinical response and plasma haloperidol levels in schizophreniaPsychopharmacology, 1983
- THERAPEUTIC WINDOW FOR PLASMA HALOPERIDOL IN ACUTE SCHIZOPHRENIC PSYCHOSISThe Lancet, 1983
- RBC and plasma levels of haloperidol and clinical response in schizophreniaAmerican Journal of Psychiatry, 1982
- Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patientsPsychopharmacology, 1981
- Relationship of serum haloperidol levels to clinical response in schizophrenic patientsAmerican Journal of Psychiatry, 1981
- Molecular pathology of schizophrenia: more than one disease process?BMJ, 1980
- High dosage haloperidol therapy in chronic schizophrenic patients: A double-blind study of clinical response, side effects, serum haloperidol, and serum prolactinPsychopharmacology, 1980
- Radioimmunoassay of bromperidol and haloperidol in human and canine plasmaEuropean Journal of Drug Metabolism and Pharmacokinetics, 1980